Cart
sales@molnova.com
Hydroxytacrine maleate
CAS No. 118909-22-1
Hydroxytacrine maleate( —— )
Catalog No. M33745 CAS No. 118909-22-1
Hydroxytacrine maleate (Velnacrine maleate) is a cholinesterase (cholinesterase) inhibitor that enhances memory in rodents and may be used in the study of Alzheimer's dementia of the Alzheimer type (SDAT).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 29 | In Stock |
|
| 50MG | 45 | In Stock |
|
| 100MG | 73 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxytacrine maleate
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxytacrine maleate (Velnacrine maleate) is a cholinesterase (cholinesterase) inhibitor that enhances memory in rodents and may be used in the study of Alzheimer's dementia of the Alzheimer type (SDAT).
-
DescriptionVelnacrine maleate (HP 029) is an orally active cholinesterase inhibitor that can be used for the research of Alzheimer's disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetAChE
-
RecptorAChE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number118909-22-1
-
Formula Weight330.34
-
Molecular FormulaC17H18N2O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 30 mg/mL (90.82 mM)
-
SMILESC(=C\C(O)=O)\C(O)=O.NC1=C2C(=NC=3C1=CC=CC3)CCCC2O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Murphy MF, et al. Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease. Ann N Y Acad Sci. 1991;640:253-62.?
molnova catalog
related products
-
TAK-802
A potent acetylcholinesterase (AChE) inhibitor with IC50 of 1.3 nM.
-
Dichlorvos
It belongs to organophosphate compounds used as a kind of common environmental health insecticide.
-
AChE/BChE-IN-10
AChE/BChE-IN-10 is a potent dual inhibitor of AChE and BChE with IC50 values of 0.176, and 0.47 μM, respectively. AChE/BChE-IN-10 exhibits good blood brain barrier permeability. AChE/BChE-IN-10 can inhibit Aβ-aggregation.
